Greetje J. de Grooth

Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans

Greetje J. de Grooth, Jan Albert Kuivenhoven, Anton F. H. Stalenhoef et al. · Circulation · 2002 · 451 citations · Full text

Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II Dyslipidemia

Jan Albert Kuivenhoven, Greetje J. de Grooth, Hitoshi Kawamura et al. · The American Journal of Cardiology · 2005 · 171 citations

Lipid Disorder, Type Ii Dyslipidemia, Oxysterol +8

Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS)

Anke H.E.M. Klerkx, Greetje J. de Grooth, Aeilko H. Zwinderman et al. · European Journal of Clinical Investigation · 2004 · 103 citations

The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia

Greetje J. de Grooth, Tineke J. Smilde, Sanne van Wissen et al. · Atherosclerosis · 2004 · 83 citations

Metabolic Syndrome, Familial Hypercholesterolemia, Oxysterol +8

The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome

Greetje J. de Grooth, Kim E. Zerba, Shu‐Pang Huang et al. · Journal of the American College of Cardiology · 2004 · 66 citations

Cardiovascular Disease, Medicine, Genetic Epidemiology +10